Acute Lymphoblastic Leukemia in a Patient Treated with Letrozole and Palbociclib / 한국유방암학회지
Journal of Breast Cancer
; : 100-106, 2020.
Article
ي En
| WPRIM
| ID: wpr-811192
المكتبة المسؤولة:
WPRO
ABSTRACT
Palbociclib, in conjunction with endocrine therapy, has been approved for the treatment of patients with advanced breast cancer. The common hematological toxicities associated with palbociclib are leukopenia and neutropenia. However, hematological malignancies have not been reported for palbociclib treatment. Here, for the first time, we present a case of acute lymphoblastic leukemia that was diagnosed in a patient undergoing treatment with letrozole and palbociclib for metastatic breast cancer. This case emphasizes the need for long term follow up of patients treated with palbociclib.
النص الكامل:
1
الفهرس:
WPRIM
نوع الدراسة:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
اللغة:
En
مجلة:
Journal of Breast Cancer
السنة:
2020
نوع:
Article